Role of high-sensitivity C-reactive protein as a marker of inflammation in pre-dialysis patients of chronic renal failure

Journal, Indian Academy of Clinical Medicine

Volumn 10, Issue 1-2, 2009, Pages 18-22

  Nand, N ^a   Aggarwal, H K ^a   Yadav, R K ^a   Gupta, A ^a   Sharma, M ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cardiovascular disease; End stage renal disease; Erythropoietin; Haemodialysis

Indexed keywords

C REACTIVE PROTEIN; ERYTHROPOIETIN; HEMOGLOBIN; SERUM ALBUMIN;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CREATININE CLEARANCE; DISEASE COURSE; FEMALE; FOLLOW UP; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFLAMMATION; MALE; MORBIDITY; MORTALITY; PREDICTION; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 67749099497     PISSN: 09723560     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Hakim RM, Lazarus JM. Initiation of dialysis. J Am Soc Nephrol 1995; 6: 1319-1328
2. Menon V, Wang X, Greene T et al. Relationship between Creactive protein, albumin and cardiovascular disease in patients with chronic kidney disease. Am J Kidney Dis 2003; 42: 44-52. (Pubitemid 36807653)
3. Lowrie EG, Lew NL. Death risk in haemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990; 15: 458-482
4. Barany P. Inflammation, serum C-reactive protein and erythropoietin resistance. Nephrol Dial Transplant 2001; 16: 224-227 (Pubitemid 32123906)
5. Pepys MB, Hirschfield GM. C-reactive protein: A critical update. J Clin Invest 2003; 111: 1805-1812
6. Tsirpanlis G. The pattern of inflammation and a potential new clinical meaning and usefulness of C-reactive protein in end-stage renal failure patients. Kidney Blood Press Res 2005; 28: 55-61. (Pubitemid 40069637)
7. Ortega O, Rodriguez I, Gallar P et al. Vigil significance of high C-reactive protein levels in pre-dialysis patients. Nephrol Dial Transplant 2002; 17 (6): 1105-1109 (Pubitemid 34746216)
8. Herzig KA, Purdie DM, Cheng W. Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients? J Am Soc Nephrol 2001; 12: 814-821 (Pubitemid 32246710)
9. Stenvinkel P, Lindholm B. C-reactive protein in end-stage renal disease: are there reasons to measure it? Blood Purif 2005; 23: 72-78 (Pubitemid 40082247)
10. Kaysen GA. Microinflammatory state in uraemia: causes and potential consequences. J Am Soc Nephrol 2001; 12: 1549-1557
11. Stenvinkel P, Lindholm B. C-reactive protein in end-stage renal disease: Are there reasons to measure it? Blood Purif 2005; 23: 72-78 (Pubitemid 40082247)
12. Wanner C, Metzger T. C-reactive protein a marker for allcause and cardiovascular mortality in haemodialysis patients. Nephrol Dial Transplant 2002; 17 (Suppl 8): 29-32. (Pubitemid 34918876)
13. Utaka S, Avesani CM, Draibe SA et al. Inflammation is associated with increased energy expenditure in patients with chronic kidney disease. Am J Clin Nutr 2005; 82 (4): 801-805 (Pubitemid 43779693)
14. Jelkmann W. Proinflammatory cytokines lowering erythropoietin production. J Interferon Cytokine Res 1998; 18: 555-559 (Pubitemid 28391581)
15. Barany P. Inflammation, serum C-reactive protein and erythropoietin resistance. Nephrol Dial Transplant 2001; 16: 224-227 (Pubitemid 32123906)
16. Kaysen GA. Microinflammatory state in uraemia: causes and potential consequences. J Am Soc Nephrol 2001; 12: 1549-1557
17. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340: 115-126
18. Moshage HJ, Janssen JAM, Franssen JH et al. Study of the molecular mechanism of decreased liver synthesis of albumin and inflammation. J Clin Invest 1987; 79: 1635-1641 (Pubitemid 17117267)
19. Ritchie RF, Palomaki GE, Neveux LM et al. Reference distributions for the negative acute-phase serum proteins, albumin, transferrin and transthyretin: a practical, simple and clinically relevant approach in a large cohort. J Clin Lab Anal 1999; 13: 273-279